menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Programs

  • From Heterogeneity Comes New Insights: Exploring the Role of T Cells & OX40 Sig…
    Medical Industry Feature

    From Heterogeneity Comes New Insights: Exploring the Role of T Cells & OX40 Signaling in Atopic Dermatitis

  • Equity in Flu Vaccine Rates: Bridging Racial & Ethnic Gaps
    VacciNation

    Equity in Flu Vaccine Rates: Bridging Racial & Ethnic Gaps

  • Identifying the Impact of RSV in Adults
    Deep Breaths: Updates from CHEST

    Identifying the Impact of RSV in Adults

  • Achieving Success in IgAN & FSGS
    CME/CE

    Achieving Success in IgAN & FSGS

    0.25 credits
  • Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patie…
    CME/CE

    Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Primary Care Module

    0.50 credits
  • Bridging the Gap to Care: What You Need to Know About ATTR-CM Amyloidosis
    CME/CE

    Bridging the Gap to Care: What You Need to Know About ATTR-CM Amyloidosis

    0.25 credits

Clinical Practice

  • From Monoamines to Neurocircuits: Our Evolving Understanding of Depression
    Medical Industry Feature

    From Monoamines to Neurocircuits: Our Evolving Understanding of Depression

  • Building Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterolo…
    CME/CE Meeting

    October 22, 2023

    07:30 PM - 09:30 PM PDT

    Building Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterologists

  • How to Tailor Treatment Plans for Patients with Recurrent Ovarian Cancer
    Project Oncology®

    How to Tailor Treatment Plans for Patients with Recurrent Ovarian Cancer

  • Examining Real-World Evidence on Flu Vaccine Effectiveness
    VacciNation

    Examining Real-World Evidence on Flu Vaccine Effectiveness

  • What to Know About PARP Inhibitors for Advanced Ovarian Cancer
    Project Oncology®

    What to Know About PARP Inhibitors for Advanced Ovarian Cancer

  • Addressing Patient Management in ASCVD Risk Reduction: A Collaborative Approach
    CME/CE Broadcast Replay

    Addressing Patient Management in ASCVD Risk Reduction: A Collaborative Approach

    1.00 credits

Doctors Lounge

  • Influenza Vaccination: The Key to Reducing Hospitalizations & Disease Severity
    VacciNation

    Influenza Vaccination: The Key to Reducing Hospitalizations & Disease Severity

  • What One Couple Learned Travelling the World with Locum Tenens
    Spotlight on Locum Tenens

    What One Couple Learned Travelling the World with Locum Tenens

  • Clinical Minute: Comparing Two Methods of Cataract Surgical Planning
    Eye on Ocular Health

    Clinical Minute: Comparing Two Methods of Cataract Surgical Planning

  • Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic…
    Project Oncology®

    Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic Burden

  • Poster Pearl: Long-Term Clinical Outcomes of Cancers Diagnosed Following Detect…
    Project Oncology®

    Poster Pearl: Long-Term Clinical Outcomes of Cancers Diagnosed Following Detection by a Blood-Based MCED Test

  • How to Recognize & Manage an Angry Patient
    GI Insights

    How to Recognize & Manage an Angry Patient

CME

  • A Look at the Numbers: Cost of Durable Treatments in Retinal Disease
    MinuteCE®

    A Look at the Numbers: Cost of Durable Treatments in Retinal Disease

    1.00 program credits
  • NASH: An Epidemic with Significant Implications for Managed Care Professionals
    CME/CE Meeting

    October 18, 2023

    06:00 PM - 08:00 PM EDT

    NASH: An Epidemic with Significant Implications for Managed Care Professionals

  • Real-World Outcomes with Durable Treatments for Retinal Diseases
    MinuteCE®

    Real-World Outcomes with Durable Treatments for Retinal Diseases

    1.00 program credits
  • What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
    CME/CE

    What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia

    0.25 credits
  • Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
    CME/CE Live Broadcast

    October 02, 2023

    06:30 PM - 07:30 PM PDT

    Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN

  • Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
    CME/CE

    Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes

    0.50 credits

Industry Feature

  • Navigating mCRC: A Closer Look at Biomarker Testing
    Medical Industry Feature

    Navigating mCRC: A Closer Look at Biomarker Testing

  • Switching to a Different Treatment: A Look Into a Subcutaneous Treatment Option…
    Medical Industry Feature

    Switching to a Different Treatment: A Look Into a Subcutaneous Treatment Option for RMS

  • Durable Hct Control in Patients with Polycythemia Vera
    Medical Industry Feature

    Durable Hct Control in Patients with Polycythemia Vera

  • Managing Anemia in Patients With Myelofibrosis
    Medical Industry Feature

    Managing Anemia in Patients With Myelofibrosis

  • ASCVD Risk Reduction in Patients With T2D
    Medical Industry Feature

    ASCVD Risk Reduction in Patients With T2D

  • Addressing Hesitancy on Biosimilars: From Development to Clinical Practice
    Medical Industry Feature

    Addressing Hesitancy on Biosimilars: From Development to Clinical Practice

Schedule28 Sep 2023